A Phase 1 patient trial of the novel, oral therapy candidate, alpha-TEA, for advanced HER2 positive breast cancer is…
emcguinnAugust 28, 2020
Last week the National Cancer Institute released some good news for patients with lung cancer: improved…
emcguinnAugust 26, 2020
Humans do not develop disease overnight. Rather, diseases develop gradually over years — sometimes decades…
emcguinnAugust 25, 2020
HHMI scientists are joining many of their colleagues worldwide in working to combat the new…
emcguinnAugust 24, 2020
Chinook Therapeutics, a biotech company creating targeted therapies for kidney diseases, raised an additional $106…
emcguinnAugust 21, 2020
It takes a persistent scientist to stop a persistent virus. A decade ago, Fred Hutchinson…
emcguinnAugust 20, 2020
When people think of neuroscience, they think of neurons, the cells that receive and transmit…
emcguinnAugust 19, 2020
When Microsoft co-founder Paul Allen put up $125 million in seed money for a Seattle institute focused…
emcguinnAugust 19, 2020
Mukesh K. Jain, M.D., remembers the exact moment that COVID-19 complications clicked into focus for…
emcguinnAugust 18, 2020
